Detalhe da pesquisa
1.
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
Eur Heart J
; 44(8): 668-677, 2023 02 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36632831
2.
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial.
Eur Heart J
; 44(24): 2202-2212, 2023 06 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37051752
3.
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
N Engl J Med
; 381(17): 1609-1620, 2019 10 24.
Artigo
Inglês
| MEDLINE | ID: mdl-31475794
4.
Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction.
Circulation
; 142(13): 1236-1245, 2020 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-32845715
5.
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.
Circulation
; 140(17): 1369-1379, 2019 10 22.
Artigo
Inglês
| MEDLINE | ID: mdl-31510768
6.
Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF.
Eur Heart J
; 38(15): 1132-1143, 2017 04 14.
Artigo
Inglês
| MEDLINE | ID: mdl-28158398
7.
Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).
Circulation
; 133(23): 2254-62, 2016 Jun 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27143684
8.
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
N Engl J Med
; 371(11): 993-1004, 2014 Sep 11.
Artigo
Inglês
| MEDLINE | ID: mdl-25176015
9.
The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.
Am Heart J
; 188: 35-41, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28577679
10.
Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.
Cardiovasc Drugs Ther
; 31(4): 445-458, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28735360
11.
Sacubitril/Valsartan (LCZ696) in Heart Failure.
Handb Exp Pharmacol
; 243: 133-165, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28004291
12.
Geographic variations in the PARADIGM-HF heart failure trial.
Eur Heart J
; 37(41): 3167-3174, 2016 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27354044
13.
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Circulation
; 131(1): 54-61, 2015 Jan 06.
Artigo
Inglês
| MEDLINE | ID: mdl-25403646
14.
Treatment Effects of Sacubitril/Valsartan Compared With Valsartan by Ejection Fraction in Patients With Recent Hospitalization.
J Card Fail
; 27(9): 1027-1030, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34133969
15.
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF.
Eur Heart J
; 36(38): 2576-84, 2015 Oct 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26231885
16.
Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failure.
Eur J Heart Fail
; 26(2): 245-256, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38124454
17.
Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure.
J Am Coll Cardiol
; 83(22): 2148-2159, 2024 Jun 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38588927
18.
Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan.
ESC Heart Fail
; 11(1): 65-77, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37813587
19.
Trajectory and correlates of pulmonary congestion by lung ultrasound in patients with acute myocardial infarction: insights from PARADISE-MI.
Eur Heart J Acute Cardiovasc Care
; 12(3): 155-164, 2023 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36649251
20.
Incremental prognostic value of biomarkers in PARADIGM-HF.
Eur J Heart Fail
; 25(8): 1406-1414, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37191207